• 1. Gansu University of Chinese Medicine, Lanzhou 730000, P. R. China;
  • 2. Gansu Provincial Maternal and Child Health Hospital (Gansu Provincial Central Hospital), Lanzhou 730050, P. R. China;
  • 3. Evidence-Based Medicine Center, School of Basic Medicine, Lanzhou University, Lanzhou 730000, P. R. China;
  • 4. Health Technology Assessment Center/Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou 730000, P. R. China;
  • 5. Gansu Provincial Industry Technology Center for Medical Big Data and Health Technology Assessment, Lanzhou 730000, P. R. China;
YANG Kehu, Email: yangkh@lzu.edu.cn; SHI Jingyun, Email: sjy20020608@163.com
Export PDF Favorites Scan Get Citation

Objective To systematically evaluate the preventive effect of fish oil-containing lipid emulsions on neonatal cholestasis. Methods The CNKI, WanFang Data, VIP, CBM, PubMed, Embase, Web of Science and Cochrane Library databases were systematically searched from inception to February 2026 to identify randomized controlled trials (RCTs) evaluating the preventive effect of fish oil-containing lipid emulsions on neonatal cholestasis. Two investigators independently performed literature screening, data extraction, and quality assessment. Meta-analysis was performed using RevMan 5.3 software. Results A total of 25 RCTs involving 2 271 participants were included. Meta-analysis showed that, compared with lipid emulsions without fish oil, the use of fish oil-containing lipid emulsions significantly reduced the incidence of neonatal cholestasis (RR=0.56, 95%CI 0.44 to 0.72, P<0.001), moderately decreased direct bilirubin levels (MD=?0.13 mg/dL, 95%CI ?0.24 to ?0.01, P<0.05), and shortened the length of hospital stay (MD=?3.94 days, 95%CI ?5.82 to ?2.06, P<0.001). The effects were more pronounced in neonates with gestational age ≥28 weeks, parenteral nutrition (PN) duration ≥14 days, and birth weight ≥1000 g. No significant advantages were observed in reducing the incidence of neonatal sepsis (P=0.47) or mortality (P=0.35). Conclusion Fish oil-containing lipid emulsions can effectively prevent the occurrence of neonatal cholestasis, reduce direct bilirubin levels, and shorten the length of hospital stay, with more definite benefits particularly in neonates with PN duration ≥14 days and gestational age ≥28 weeks.

Citation: LI Juan, ZHAO Fangping, NIAN Tao, OUYANG Changping, WANG Min, YANG Dongdong, LI Xiuxia, YI Bin, YANG Kehu, SHI Jingyun. Fish oil-containing lipid emulsions for the prevention of parenteral nutrition-associated cholestasis in neonates: a systematic review and meta-analysis. Chinese Journal of Evidence-Based Medicine, 2026, 26(10): 1174-1181. doi: 10.7507/1672-2531.202604076 Copy

Copyright ? the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved

  • Previous Article

    Prognostic value of ctDNA status in patients with triple-negative breast cancer undergoing neoadjuvant therapy: a meta-analysis
  • Next Article

    Pharmacoeconomic evaluation of first-line treatment regimens for unresectable hepatocellular carcinoma in China